In support of this protective role for ACE2, pharmaceutical preparations of recombinant ACE2, when administered to experimental animals, protect against lung cell death, inhibit acute lung injury and prevent lung fibrosis after chronic injury to the lungs (Samavati and Uhal 2020). This evidence concerns the gene ACE2 and pulmonary fibrosis.